AbbVie (ABBV) Q4 2021 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Elizabeth Shea — Vice President, Investor Relations Richard A. Gonzalez — Chairman of the Board and…
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its fourth-quarter financial results for the period ended December 31, 2021. Net revenues increased 7.4% to $14.8 billion. Net income…
Market News
AbbVie (ABBV) stock research summary | Q3 2021
The AlphaStreet research report provides actionable data and insights into AbbVie’s fundamentals, the industry, and competition. The report is meant as a resource for investors…
Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues
Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The results also exceeded Wall Street’s…
AbbVie (ABBV) AbbVie to Host Third-Quarter 2021 Earnings Conference Call
AbbVie (NYSE: ABBV) Q3 2021 Earnings Conference
AbbVie Inc (ABBV) Q2 2021 Earnings Call Transcript
AbbVie Inc (NYSE: ABBV) Q2 2021 earnings call dated July 30, 2021 Corporate Participants: Liz Shea — Vice President of Investor Relations Richard A. Gonzalez — Chairman of the…
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its second-quarter financial results for the period ended June 30, 2021. Net revenues increased 34% to $13.9 billion. Net income…
AbbVie (ABBV) AbbVie to Host Second-Quarter 2021 Earnings Conference Call
AbbVie (NYSE: ABBV) Q2 2021 Earnings Conference
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its first quarter financial results for the period ended March 31, 2021. Net income for the first quarter was $3.55…
Analysis
AbbVie (ABBV) Stock: Here’s what you need to know before investing
AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant’s flagship product whose patent is…